HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Claudio Zavanella Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miyamoto, K. Articles by Subramanian, S. Search for Related Content PubMed PubMed Citation Articles by Miyamoto, K. Articles by Subramanian, S.

Ann Thorac Surg 1979;27:413-417
© 1979 The Society of Thoracic Surgeons

---

Articles

Aorta–Pulmonary Artery Shunts with Expanded Polytetrafluoroethylene (PTFE) Tube

Department of Cardiovascular Surgery, Children's Hospital, Buffalo, NY

Accepted for publication August 28, 1978.

^* Address reprint requests to Dr. Subramanian, Division of Cardiovascular Surgery, Children's Hospital, 219 Bryant St, Buffalo, NY 14222

Ten patients underwent an aorta-pulmonary artery shunt with a polytetrafluoroethylene (PTFE) tube between December, 1976, and October, 1977. Five of them were less than 1 month old. The diameter of the PTFE tube was 5 mm in 9 patients and 4 mm in 1 patient. Seven patients survived the operation. One of them had a clotted shunt, which was reoperated on successfully. Three patients died in the postoperative period, and all had a patent shunt. Overall patency was 90% (9/10). Congestive heart failure refractory to medical treatment developed in 1 patient with a patent Blalock-Taussig and PTFE shunt. In our institution, the Blalock-Taussig shunt is the procedure of choice. The PTFE shunt is used when the anatomy of a patient is unsuitable for a Blalock-Taussig shunt. A tube diameter of 5 mm is optimal for infants when further growth is considered, even if digitalization is necessary to control congestive heart failure.

This article has been cited by other articles:

				K. Kusuhara, S. Miki, Y. Ueda, Y. Ohkita, T. Tahata, and M. Komeda Optimal Flow of Aorta-Pulmonary Artery Shunt in Patients with Cyanotic Heart Disease Ann. Thorac. Surg., August 1, 1987; 44(2): 128 - 134. [Abstract] [PDF]

				J. C. Opie, L. Traverse, R. I. Hayden, C. Y. Ho, J. A. G. Culham, and P. G. Ashmore Experience with Polytetrafluoroethylene Grafts in Children with Cyanotic Congenital Heart Disease Ann. Thorac. Surg., February 1, 1986; 41(2): 164 - 168. [Abstract] [PDF]

				N. L. Mills, L. C. Williams III, and W. S. Culpepper III Technique and Experience with Azygos Patch Modified Blalock-Taussig Anastomosis for Congenital Cyanotic Heart Disease Ann. Thorac. Surg., June 1, 1985; 39(6): 547 - 551. [Abstract] [PDF]

				P. K. Woolf, L. W. Stephenson, E. Meijboom, J. H. Bavinck, T. J. Gardner, J. S. Donahoo, R. N. Edie, and L. H. Edmunds Jr. A Comparison of Blalock-Taussig, Waterston, and Polytetrafluoroethylene Shunts in Children Less Than Two Weeks of Age Ann. Thorac. Surg., July 1, 1984; 38(1): 26 - 30. [Abstract] [PDF]

				E. L. Bove, H. M. Sondheimer, R.-E. W. Kavey, C. J. Byrum, M. S. Blackman, and F. B. Parker Jr. Subclavian--Pulmonary Artery Shunts with Polytetrafluoroethylene Interposition Grafts Ann. Thorac. Surg., January 1, 1984; 37(1): 88 - 91. [Abstract] [PDF]

				J. S. Donahoo, T. J. Gardner, K. Zahka, and B. S. L. Kidd Systemic-Pulmonary Shunts in Neonates and Infants Using Microporous Expanded Polytetrafluoroethylene: Immediate and Late Results Ann. Thorac. Surg., August 1, 1980; 30(2): 146 - 150. [Abstract] [PDF]